Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Syed A Ahmad
Affiliation
University of Cincinnati College of Medicine
ORCID
Career Start Year
1996
Papers
217
H Index
49
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
37980709
ASO Practice Guidelines Series: Management of Resectable, Borderline Resectable, and Locally Advanced Pancreas Cancer.
Ann Surg Oncol
2024
36316508
Racial Disparity in Pathologic Response following Neoadjuvant Chemotherapy in Resected Pancreatic Cancer: A Multi-Institutional Analysis from the Central Pancreatic Consortium.
Ann Surg Oncol
2023
37020094
FOLFIRINOX or Gemcitabine-based Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: A Multi-institutional, Patient-Level, Meta-analysis and Systematic Review.
Ann Surg Oncol
2023
37246980
Acid sphingomyelinase expression is associated with survival in resectable pancreatic ductal adenocarcinoma.
J Mol Med (Berl)
2023
36943918
Analysis of the fecal metagenome in long-term survivors of pancreas cancer.
Cancer
2023
37067744
ASO Visual Abstract: FOLFIRINOX or Gemcitabine Based Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: A Multi-Institutional, Patient-Level Meta-Analysis and Systematic Review.
Ann Surg Oncol
2023
36790532
Simultaneous targeting of mitochondrial Kv1.3 and lysosomal acid sphingomyelinase amplifies killing of pancreatic ductal adenocarcinoma cells in vitro and in vivo.
J Mol Med (Berl)
2023
36622529
Adjuvant Chemoradiation in Patients with Lymph Node-Positive Biliary Tract Cancers: Secondary Analysis of a Single-Arm Clinical Trial (SWOG 0809).
Ann Surg Oncol
2023
36542251
ASO Visual Abstract: Adjuvant Chemoradiation in Patients with Lymph Node-Positive Biliary Tract Cancers - Secondary Analysis of a Single-Arm Clinical Trial (SWOG 0809).
Ann Surg Oncol
2023
36564655
ASO Visual Abstract: Racial Disparity in Pathologic Response Following Neoadjuvant Chemotherapy in Resected Pancreatic Cancer-A Multi-institutional Analysis from the Central Pancreatic Consortium.
Ann Surg Oncol
2023
36727736
Long-Term Survival Outcomes after Operative Management of Chronic Pancreatitis: Two Decades of Experience.
J Am Coll Surg
2023
36410925
Clinical Trials in Surgical Oncology.
Surg Oncol Clin N Am
2023
36241471
Predicting endocrine function after total pancreatectomy and islet cell autotransplantation: A novel approach utilizing computed tomography texture analysis.
Surgery
2023
36028353
Microsatellite instability is associated with worse overall survival in resectable colorectal liver metastases.
Am J Surg
2023
34839055
A national Danish proof of concept on feasibility and safety of home -based intensive chemotherapy in patients with acute myeloid leukemia.
Leuk Res
2022
35511392
Intraoperative Pancreatic Neck Margin Assessment During Pancreaticoduodenectomy for Pancreatic Adenocarcinoma in the Era of Neoadjuvant Therapy: A Multi-institutional Analysis from the Central Pancreatic Consortium.
Ann Surg Oncol
2022
35441906
A National Assessment of T2 Staging for Intrahepatic Cholangiocarcinoma and the Poor Prognosis Associated with Multifocality.
Ann Surg Oncol
2022
35357614
Is There a Benefit to Adjuvant Chemotherapy in Resected, Early Stage Pancreatic Ductal Adenocarcinoma?
Ann Surg Oncol
2022
35743476
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: A Summary of Key Clinical Trials.
J Clin Med
2022
35681598
Inhibition of a Mitochondrial Potassium Channel in Combination with Gemcitabine and Abraxane Drastically Reduces Pancreatic Ductal Adenocarcinoma in an Immunocompetent Orthotopic Murine Model.
Cancers (Basel)
2022
36539400
Pharmacological targeting of the mitochondrial calcium-dependent potassium channel KCa3.1 triggers cell death and reduces tumor growth and metastasis in vivo.
Cell Death Dis
2022
35927127
Total pancreatectomy and islet cell autotransplantation: a 10-year update on outcomes and assessment of long-term durability.
HPB (Oxford)
2022
36258061
Do Lymph Node Metastases Matter in Appendiceal Cancer with Peritoneal Carcinomatosis? A US HIPEC Collaborative Study.
J Gastrointest Surg
2022
35038967
Severity and 90-day survival of SARS-CoV-2 infection among patients with haematological disorders.
Acta Oncol
2022
35090793
Is endocrine and exocrine function improved following duodenal preserving pancreatic head resection over whipple for chronic pancreatitis?
HPB (Oxford)
2022
35034793
Radiation therapy in borderline resectable pancreatic cancer: A review.
Surgery
2022
35141802
Systemic Therapy for Resected Pancreatic Adenocarcinoma: How Much is Enough?
Ann Surg Oncol
2022
32939853
SARS-CoV-2 infection among patients with haematological disorders: Severity and one-month outcome in 66 Danish patients in a nationwide cohort study.
Eur J Haematol
2021
34395257
A First-In-Class, Humanized Antibody Targeting Alternatively Spliced Tissue Factor: Preclinical Evaluation in an Orthotopic Model of Pancreatic Ductal Adenocarcinoma.
Front Oncol
2021
34210643
Corrigendum to "Insight into the mechanism of cytotoxicity of membrane-permeant psoralenic Kv1.3 channel inhibitors by chemical dissection of a novel member of the family" [Redox Biol. 37 (2020 Sep 6) 101705-101721].
Redox Biol
2021
34033222
Targeting CXCR1/2 in the first multicenter, double-blinded, randomized trial in autologous islet transplant recipients.
Am J Transplant
2021
34047859
The Landmark Series: Preoperative Therapy for Pancreatic Cancer.
Ann Surg Oncol
2021
33086320
A Call for Caution in Overinterpreting Exceptional Outcomes After Radical Surgery for Pancreatic Cancer: Let the Data Speak.
Ann Surg
2021
33059910
Evaluating the Impact of ESPAC-1 on Shifting the Paradigm of Pancreatic Cancer Treatment.
J Surg Res
2021
33139382
Acid Ceramidase Rescues Cystic Fibrosis Mice from Pulmonary Infections.
Infect Immun
2021
33475684
Efficacy of Perioperative Chemotherapy for Resectable Pancreatic Adenocarcinoma: A Phase 2 Randomized Clinical Trial.
JAMA Oncol
2021
33323311
Preoperative ERCP has no impact on islet yield following total pancreatectomy and islet autotransplantation (TPIAT): Results from the Prospective Observational Study of TPIAT (POST) cohort.
Pancreatology
2021
33201456
Lack of National Adoption of Evidence-Based Treatment for Resectable Gastric Adenocarcinoma.
J Gastrointest Surg
2021
31428960
Should We Be Doing Cytoreductive Surgery with HIPEC for Signet Ring Cell Appendiceal Adenocarcinoma? A Study from the US HIPEC Collaborative.
J Gastrointest Surg
2020
31745897
Sterility Cultures Following Pancreatectomy with Islet Autotransplantation in the Pediatric Population: Do They Matter?
J Gastrointest Surg
2020
31745888
Readmissions After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: a US HIPEC Collaborative Study.
J Gastrointest Surg
2020
31767364
Outcome of delayed versus timely esophagectomy after chemoradiation for esophageal adenocarcinoma.
J Thorac Cardiovasc Surg
2020
33163980
Pharmacological Inhibition of Acid Sphingomyelinase Prevents Uptake of SARS-CoV-2 by Epithelial Cells.
Cell Rep Med
2020
33381507
Voltage-Gated Potassium Channels as Regulators of Cell Death.
Front Cell Dev Biol
2020
33348809
Murine- and Human-Derived Autologous Organoid/Immune Cell Co-Cultures as Pre-Clinical Models of Pancreatic Ductal Adenocarcinoma.
Cancers (Basel)
2020
33007503
Insight into the mechanism of cytotoxicity of membrane-permeant psoralenic Kv1.3 channel inhibitors by chemical dissection of a novel member of the family.
Redox Biol
2020
32864043
Comparison of open and closed hyperthermic intraperitoneal chemotherapy: Results from the United States hyperthermic intraperitoneal chemotherapy collaborative.
World J Gastrointest Oncol
2020
32917722
Sphingosine prevents binding of SARS-CoV-2 spike to its cellular receptor ACE2.
J Biol Chem
2020
32740235
Surgical Outcome Results From SWOG S1505: A Randomized Clinical Trial of mFOLFIRINOX Versus Gemcitabine/Nab-paclitaxel for Perioperative Treatment of Resectable Pancreatic Ductal Adenocarcinoma.
Ann Surg
2020
32658077
Patterns of Failure After Neoadjuvant Stereotactic Body Radiation Therapy or Fractionated Chemoradiation in Resectable and Borderline Resectable Pancreatic Cancer.
Pancreas
2020
1 - 50 of 217
Column Actions
Search
Recommended Authors
Francisco Laxague
Schulich School of Medicine & Dentistry, Western University
Career Start Year
2018
Number of shared co-authors
0
Ian Solsky
Wake Forest University
Career Start Year
2015
Number of shared co-authors
0
Alex B Blair
Johns Hopkins University School of Medicine
Career Start Year
2015
Number of shared co-authors
0
Ian W Folkert
Perelman School of Medicine, University of Pennsylvania
Career Start Year
2015
Number of shared co-authors
0
Patrick W Underwood
College of Medicine, University of Florida
Career Start Year
2014
Number of shared co-authors
0
Ammara A Watkins
Lahey Hospital and Medical Center
Career Start Year
2014
Number of shared co-authors
0
Cheryl Meguid
University of Colorado
Career Start Year
2014
Number of shared co-authors
0
Daniel Delitto
Stanford University School of Medicine
Career Start Year
2014
Number of shared co-authors
0
Nicholas Brian Shannon
Singapore General Hospital
Career Start Year
2010
Number of shared co-authors
0
Ryan J Ellis
Memorial Sloan Kettering Cancer Center
Career Start Year
2008
Number of shared co-authors
0
Patricio M Polanco
University of Texas Southwestern Medical Center
Career Start Year
2006
Number of shared co-authors
1
Samuel Eisenstein
University of California San Diego
Career Start Year
2004
Number of shared co-authors
1
Itzhak Avital
Goldman School of Medicine, Ben Gurion University
Career Start Year
2001
Number of shared co-authors
0
Marco Del Chiaro
University of Colorado
Career Start Year
2001
Number of shared co-authors
1
Thomas J George
UF Health Cancer Center
Career Start Year
1998
Number of shared co-authors
2
Alexandra M Easson
University of Toronto
Career Start Year
1996
Number of shared co-authors
0
Victor M Zaydfudim
Surgical Outcomes Research Center, University of Virginia
Career Start Year
1996
Number of shared co-authors
1
Udo Rudloff
Center for Cancer Research, National Cancer Institute
Career Start Year
1994
Number of shared co-authors
0
Hideki Ueno
National Defense Medical College
Career Start Year
1993
Number of shared co-authors
0
Oliver F Bathe
Cumming School of Medicine, University of Calgary
Career Start Year
1991
Number of shared co-authors
0
Richard J Barth
Dartmouth-Hitchcock Medical Center
Career Start Year
1990
Number of shared co-authors
2
Martin K Schilling
University Hospital of Homburg/Saar (DE)
Career Start Year
1990
Number of shared co-authors
0
Stephen W Behrman
430482University of Tennessee Health Science Center
Career Start Year
1990
Number of shared co-authors
1
Kevin E Behrns
University of Florida Central Florida USA.
Career Start Year
1989
Number of shared co-authors
0
Martin D McCarter
University of Colorado School of Medicine
Career Start Year
1989
Number of shared co-authors
1
Yong Hyun Park
James Buchanan Brady Urological Institute, Johns Hopkins School of Medicine
Career Start Year
1987
Number of shared co-authors
1
Al B Benson
Northwestern University Feinberg School of Medicine
Career Start Year
1984
Number of shared co-authors
4
Richard D Schulick
University of Colorado School of Medicine
Career Start Year
1983
Number of shared co-authors
0
Cornelis J H van de Velde
Leiden University Medical Center: Leids Universitair Medisch Centrum.
Career Start Year
1977
Number of shared co-authors
2
Kenneth Eng
Caryl and Israel Englander Institute for Precision Medicine
Career Start Year
1971
Number of shared co-authors
0
row(s) 1 - 30 of 30
Collaborators
Andrew M Lowy
University of California San Diego
Co-authored papers
26
Aaron M Delman
University of Cincinnati College of Medicine
Co-authored papers
10
Vladimir Y Bogdanov
University of Cincinnati College of Medicine
Co-authored papers
5
Joel M Baumgartner
University of California
Co-authored papers
4
Timothy B Gardner
Dartmouth-Hitchcock Medical Center
Co-authored papers
3
Dusten Unruh
Feinberg School of Medicine, Northwestern University
Co-authored papers
3
Raphael E Pollock
James Cancer Center, The Ohio State University
Co-authored papers
2
Patrick Van Dreden
Institut Universitaire de Cancerologie (IUC), Sorbonne Universite
Co-authored papers
2
Eric A Collisson
University of California san francisco
Co-authored papers
2
Barry Woodhams
Haemacon Ltd
Co-authored papers
2
Bruce J Aronow
Cincinnati Children's Hospital Medical Center
Co-authored papers
2
Kelly K Hunt
The University of Texas MD Anderson Cancer Center
Co-authored papers
2
Judy C Boughey
Mayo Clinic
Co-authored papers
2
Robert S Franco
University of Cincinnati College of Medicine
Co-authored papers
2
Samuel F Hohmann
Vizient Inc.
Co-authored papers
2
Kerrington D Smith
Dartmouth-Hitchcock Medical Center
Co-authored papers
2
Andrea Urbani
National Research Council (CNR)
Co-authored papers
2
Mariette Adam
Co-authored papers
2
Changchun Xie
University of Cincinnati
Co-authored papers
1
Steven R Alberts
Mayo Clinic
Co-authored papers
1
David J McConkey
Johns Hopkins School of Medicine
Co-authored papers
1
Georg Kochs
Institute of Virology, Freiburg University Medical Center, University of Freiburg
Co-authored papers
1
Spencer C Behr
University of California san francisco
Co-authored papers
1
Farah Sagin
Co-authored papers
1
Rachel Aufforth
The University of North Carolina
Co-authored papers
1
Jamie R Robinson
Vanderbilt University Medical Center
Co-authored papers
1
Florin Vaida
School of Public Health, university of california san diego
Co-authored papers
1
Alexander S Martin
Keck School of Medicine, University of Southern California
Co-authored papers
1
Mary B Palascak
University of Cincinnati College of Medicine.
Co-authored papers
1
Kenneth W Sharp
Vanderbilt University Medical Center
Co-authored papers
1
1 - 30